nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Sensitisation—Epirubicin—bone cancer	0.00614	0.0336	CcSEcCtD
Acetylcysteine—Sensitisation—Doxorubicin—bone cancer	0.00568	0.0311	CcSEcCtD
Acetylcysteine—Rhinorrhoea—Cisplatin—bone cancer	0.00527	0.0288	CcSEcCtD
Acetylcysteine—Wheezing—Cisplatin—bone cancer	0.00415	0.0227	CcSEcCtD
Acetylcysteine—Body temperature increased—Carboplatin—bone cancer	0.0041	0.0225	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Cisplatin—bone cancer	0.0032	0.0175	CcSEcCtD
Acetylcysteine—Face oedema—Cisplatin—bone cancer	0.00299	0.0164	CcSEcCtD
Acetylcysteine—Haemoptysis—Epirubicin—bone cancer	0.00296	0.0162	CcSEcCtD
Acetylcysteine—Feeling hot—Epirubicin—bone cancer	0.00279	0.0153	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Cisplatin—bone cancer	0.00277	0.0152	CcSEcCtD
Acetylcysteine—Haemoptysis—Doxorubicin—bone cancer	0.00274	0.015	CcSEcCtD
Acetylcysteine—Feeling hot—Doxorubicin—bone cancer	0.00258	0.0141	CcSEcCtD
Acetylcysteine—Thinking abnormal—Epirubicin—bone cancer	0.00239	0.0131	CcSEcCtD
Acetylcysteine—Stomatitis—Cisplatin—bone cancer	0.00233	0.0127	CcSEcCtD
Acetylcysteine—Gait disturbance—Epirubicin—bone cancer	0.00225	0.0123	CcSEcCtD
Acetylcysteine—Thinking abnormal—Doxorubicin—bone cancer	0.00222	0.0121	CcSEcCtD
Acetylcysteine—Gait disturbance—Doxorubicin—bone cancer	0.00208	0.0114	CcSEcCtD
Acetylcysteine—Flushing—Cisplatin—bone cancer	0.00199	0.0109	CcSEcCtD
Acetylcysteine—Cardiac disorder—Cisplatin—bone cancer	0.00199	0.0109	CcSEcCtD
Acetylcysteine—Immune system disorder—Cisplatin—bone cancer	0.00194	0.0106	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cisplatin—bone cancer	0.00193	0.0106	CcSEcCtD
Acetylcysteine—Mental disability—Epirubicin—bone cancer	0.0019	0.0104	CcSEcCtD
Acetylcysteine—Erythema—Cisplatin—bone cancer	0.00187	0.0102	CcSEcCtD
Acetylcysteine—Eye pain—Epirubicin—bone cancer	0.00176	0.00964	CcSEcCtD
Acetylcysteine—Mental disability—Doxorubicin—bone cancer	0.00176	0.00963	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—bone cancer	0.00176	0.00961	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Epirubicin—bone cancer	0.00164	0.009	CcSEcCtD
Acetylcysteine—Eye pain—Doxorubicin—bone cancer	0.00163	0.00892	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.00158	0.00863	CcSEcCtD
Acetylcysteine—Face oedema—Epirubicin—bone cancer	0.00154	0.00841	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cisplatin—bone cancer	0.00152	0.00833	CcSEcCtD
Acetylcysteine—Oedema—Cisplatin—bone cancer	0.00152	0.00833	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Doxorubicin—bone cancer	0.00152	0.00832	CcSEcCtD
Acetylcysteine—Tachycardia—Cisplatin—bone cancer	0.00149	0.00813	CcSEcCtD
Acetylcysteine—Skin disorder—Cisplatin—bone cancer	0.00148	0.00809	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Cisplatin—bone cancer	0.00147	0.00806	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—bone cancer	0.00147	0.00804	CcSEcCtD
Acetylcysteine—Hypotension—Cisplatin—bone cancer	0.00142	0.00779	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Epirubicin—bone cancer	0.00142	0.00779	CcSEcCtD
Acetylcysteine—Face oedema—Doxorubicin—bone cancer	0.00142	0.00778	CcSEcCtD
Acetylcysteine—Asthma—Epirubicin—bone cancer	0.00138	0.00753	CcSEcCtD
Acetylcysteine—Dyspnoea—Cisplatin—bone cancer	0.00136	0.00743	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Doxorubicin—bone cancer	0.00132	0.0072	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Cisplatin—bone cancer	0.00131	0.00719	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—bone cancer	0.00131	0.00717	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—bone cancer	0.00128	0.00699	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—bone cancer	0.00127	0.00696	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—bone cancer	0.00126	0.00687	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—bone cancer	0.00123	0.00671	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—bone cancer	0.0012	0.00659	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—bone cancer	0.0012	0.00654	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—bone cancer	0.00118	0.00643	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—bone cancer	0.00117	0.00639	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—bone cancer	0.00113	0.00621	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—bone cancer	0.00112	0.00614	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—bone cancer	0.00111	0.00605	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—bone cancer	0.00109	0.00598	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—bone cancer	0.00109	0.00597	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—bone cancer	0.00109	0.00595	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—bone cancer	0.00107	0.00584	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—bone cancer	0.00106	0.00581	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—bone cancer	0.00106	0.0058	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—bone cancer	0.00102	0.0056	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—bone cancer	0.00102	0.00559	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—bone cancer	0.00102	0.00559	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—bone cancer	0.00101	0.00553	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—bone cancer	0.000999	0.00547	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—bone cancer	0.000994	0.00544	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—bone cancer	0.000992	0.00543	CcSEcCtD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—JUN—bone cancer	0.000987	0.00121	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—JUN—bone cancer	0.000987	0.00121	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—KIT—bone cancer	0.00098	0.0012	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—JUN—bone cancer	0.00097	0.00119	CbGpPWpGaD
Acetylcysteine—Vomiting—Cisplatin—bone cancer	0.000968	0.0053	CcSEcCtD
Acetylcysteine—GRIN2D—Neuronal System—MDM2—bone cancer	0.000965	0.00118	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—KIT—bone cancer	0.000965	0.00118	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000963	0.00118	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—JUN—bone cancer	0.000963	0.00118	CbGpPWpGaD
Acetylcysteine—Rash—Cisplatin—bone cancer	0.00096	0.00525	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—bone cancer	0.000959	0.00525	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—bone cancer	0.000958	0.00524	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—JUN—bone cancer	0.000956	0.00117	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—JUN—bone cancer	0.000953	0.00117	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—JUN—bone cancer	0.000946	0.00116	CbGpPWpGaD
Acetylcysteine—GRIN2A—Neuronal System—BRAF—bone cancer	0.000946	0.00116	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Doxorubicin—bone cancer	0.000945	0.00517	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—bone cancer	0.000945	0.00517	CcSEcCtD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—JUN—bone cancer	0.000945	0.00116	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—EGFR—bone cancer	0.00094	0.00115	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—JUN—bone cancer	0.000931	0.00114	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—JUN—bone cancer	0.000927	0.00113	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—ATF1—bone cancer	0.000927	0.00113	CbGpPWpGaD
Acetylcysteine—Angiopathy—Doxorubicin—bone cancer	0.000924	0.00506	CcSEcCtD
Acetylcysteine—CHUK—Downstream signal transduction—KIT—bone cancer	0.000921	0.00113	CbGpPWpGaD
Acetylcysteine—Immune system disorder—Doxorubicin—bone cancer	0.00092	0.00503	CcSEcCtD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL3—bone cancer	0.00092	0.00113	CbGpPWpGaD
Acetylcysteine—Mediastinal disorder—Doxorubicin—bone cancer	0.000918	0.00502	CcSEcCtD
Acetylcysteine—IKBKB—AGE/RAGE pathway—EGFR—bone cancer	0.000918	0.00112	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—KIT—bone cancer	0.000917	0.00112	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000914	0.00112	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—KIT—bone cancer	0.000912	0.00112	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000912	0.00112	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—JUN—bone cancer	0.000911	0.00111	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.000909	0.00111	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—KIT—bone cancer	0.000908	0.00111	CbGpPWpGaD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—bone cancer	0.000907	0.00111	CbGpPWpGaD
Acetylcysteine—Nausea—Cisplatin—bone cancer	0.000905	0.00495	CcSEcCtD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—JUN—bone cancer	0.000903	0.0011	CbGpPWpGaD
Acetylcysteine—GRIN1—Transmission across Chemical Synapses—MDM2—bone cancer	0.000902	0.0011	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—ENO2—bone cancer	0.000898	0.0011	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000896	0.0011	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—JUN—bone cancer	0.000895	0.0011	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—JUN—bone cancer	0.000895	0.0011	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—KIT—bone cancer	0.000895	0.00109	CbGpPWpGaD
Acetylcysteine—Cough—Methotrexate—bone cancer	0.000893	0.00489	CcSEcCtD
Acetylcysteine—SLC7A11—Hemostasis—PLAU—bone cancer	0.000889	0.00109	CbGpPWpGaD
Acetylcysteine—Erythema—Doxorubicin—bone cancer	0.000887	0.00485	CcSEcCtD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—JUN—bone cancer	0.00088	0.00108	CbGpPWpGaD
Acetylcysteine—GRIN2B—Transmission across Chemical Synapses—MDM2—bone cancer	0.000879	0.00108	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000866	0.00474	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR—BRAF—bone cancer	0.000862	0.00105	CbGpPWpGaD
Acetylcysteine—Syncope—Epirubicin—bone cancer	0.000859	0.0047	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—JUN—bone cancer	0.000858	0.00105	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—KIT—bone cancer	0.000854	0.00105	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—KIT—bone cancer	0.000854	0.00105	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—KIT—bone cancer	0.000854	0.00105	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000854	0.00104	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—KIT—bone cancer	0.000847	0.00104	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—JUN—bone cancer	0.000844	0.00103	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Epirubicin—bone cancer	0.000842	0.00461	CcSEcCtD
Acetylcysteine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—bone cancer	0.00084	0.00103	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—KIT—bone cancer	0.000839	0.00103	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—JUN—bone cancer	0.000837	0.00102	CbGpPWpGaD
Acetylcysteine—Cough—Epirubicin—bone cancer	0.000836	0.00458	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—bone cancer	0.000836	0.00457	CcSEcCtD
Acetylcysteine—CHUK—Signaling by PDGF—KIT—bone cancer	0.000835	0.00102	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—DHFR—bone cancer	0.000833	0.00102	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000831	0.00102	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MET—bone cancer	0.000827	0.00101	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—BRAF—bone cancer	0.000825	0.00101	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.000824	0.00101	CbGpPWpGaD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—TP53—bone cancer	0.00082	0.001	CbGpPWpGaD
Acetylcysteine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—bone cancer	0.000819	0.001	CbGpPWpGaD
Acetylcysteine—Skin disorder—Methotrexate—bone cancer	0.000812	0.00444	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KIT—bone cancer	0.000811	0.000993	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00081	0.00443	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—bone cancer	0.000808	0.00442	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—MDM2—bone cancer	0.000807	0.000987	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MET—bone cancer	0.000806	0.000987	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—BRAF—bone cancer	0.000804	0.000984	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—BRAF—bone cancer	0.000803	0.000982	CbGpPWpGaD
Acetylcysteine—Syncope—Doxorubicin—bone cancer	0.000795	0.00435	CcSEcCtD
Acetylcysteine—GRIN2A—Neuronal System—MDM2—bone cancer	0.000792	0.00097	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—KIT—bone cancer	0.000791	0.000967	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TP53—bone cancer	0.000789	0.000966	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—JUN—bone cancer	0.000788	0.000964	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Epirubicin—bone cancer	0.000782	0.00428	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—bone cancer	0.000782	0.00428	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—bone cancer	0.000781	0.00427	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—bone cancer	0.000779	0.00426	CcSEcCtD
Acetylcysteine—GSS—Metabolism—GNA11—bone cancer	0.000779	0.000953	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—KIT—bone cancer	0.000775	0.000948	CbGpPWpGaD
Acetylcysteine—Cough—Doxorubicin—bone cancer	0.000774	0.00423	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—MDM2—bone cancer	0.000772	0.000945	CbGpPWpGaD
Acetylcysteine—Shock—Epirubicin—bone cancer	0.000769	0.00421	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000764	0.000935	CbGpPWpGaD
Acetylcysteine—Tachycardia—Epirubicin—bone cancer	0.000763	0.00418	CcSEcCtD
Acetylcysteine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—bone cancer	0.000761	0.000932	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—MDM2—bone cancer	0.00076	0.00093	CbGpPWpGaD
Acetylcysteine—Skin disorder—Epirubicin—bone cancer	0.00076	0.00416	CcSEcCtD
Acetylcysteine—IKBKB—Activated TLR4 signalling—JUN—bone cancer	0.000759	0.000929	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—BRAF—bone cancer	0.000759	0.000929	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.000757	0.000926	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Epirubicin—bone cancer	0.000756	0.00414	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism—NDUFA12—bone cancer	0.000753	0.000921	CbGpPWpGaD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00075	0.0041	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—bone cancer	0.000745	0.00408	CcSEcCtD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—TP53—bone cancer	0.000744	0.00091	CbGpPWpGaD
Acetylcysteine—Somnolence—Methotrexate—bone cancer	0.000743	0.00407	CcSEcCtD
Acetylcysteine—CHUK—PI-3K cascade—EGFR—bone cancer	0.000738	0.000903	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Methotrexate—bone cancer	0.000736	0.00403	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—bone cancer	0.000731	0.004	CcSEcCtD
Acetylcysteine—CHUK—Downstream signal transduction—MDM2—bone cancer	0.000726	0.000888	CbGpPWpGaD
Acetylcysteine—Oedema—Doxorubicin—bone cancer	0.000724	0.00396	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—bone cancer	0.000724	0.00396	CcSEcCtD
Acetylcysteine—CHUK—Signaling by FGFR—MDM2—bone cancer	0.000722	0.000884	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000721	0.00395	CcSEcCtD
Acetylcysteine—CHUK—PI3K/AKT activation—EGFR—bone cancer	0.00072	0.000881	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—MDM2—bone cancer	0.000719	0.000879	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—KIT—bone cancer	0.000717	0.000877	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—MDM2—bone cancer	0.000715	0.000875	CbGpPWpGaD
Acetylcysteine—CHUK—GAB1 signalosome—EGFR—bone cancer	0.000715	0.000874	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—JUN—bone cancer	0.000714	0.000874	CbGpPWpGaD
Acetylcysteine—Shock—Doxorubicin—bone cancer	0.000712	0.0039	CcSEcCtD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000711	0.00087	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000709	0.000868	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CYP3A4—bone cancer	0.000706	0.000864	CbGpPWpGaD
Acetylcysteine—Tachycardia—Doxorubicin—bone cancer	0.000706	0.00386	CcSEcCtD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000705	0.000862	CbGpPWpGaD
Acetylcysteine—Skin disorder—Doxorubicin—bone cancer	0.000703	0.00385	CcSEcCtD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—JUN—bone cancer	0.000701	0.000858	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TP53—bone cancer	0.000701	0.000857	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Doxorubicin—bone cancer	0.0007	0.00383	CcSEcCtD
Acetylcysteine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—bone cancer	0.000698	0.000854	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Epirubicin—bone cancer	0.000697	0.00382	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—bone cancer	0.000695	0.0038	CcSEcCtD
Acetylcysteine—GRIN1—Neuronal System—MDM2—bone cancer	0.000691	0.000846	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP2—bone cancer	0.00069	0.000844	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—JUN—bone cancer	0.00069	0.000844	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Epirubicin—bone cancer	0.000688	0.00377	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—MMP9—bone cancer	0.000682	0.000835	CbGpPWpGaD
Acetylcysteine—Hypotension—Doxorubicin—bone cancer	0.000676	0.0037	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000675	0.00369	CcSEcCtD
Acetylcysteine—GRIN2B—Neuronal System—MDM2—bone cancer	0.000674	0.000824	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—MDM2—bone cancer	0.000673	0.000823	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—MDM2—bone cancer	0.000673	0.000823	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.000673	0.000823	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MMP2—bone cancer	0.000673	0.000823	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—MDM2—bone cancer	0.000667	0.000816	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000664	0.000812	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—bone cancer	0.000664	0.00363	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—MDM2—bone cancer	0.000661	0.000809	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Methotrexate—bone cancer	0.000661	0.00361	CcSEcCtD
Acetylcysteine—CHUK—Signaling by PDGF—MDM2—bone cancer	0.000658	0.000805	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Doxorubicin—bone cancer	0.000645	0.00353	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000643	0.000787	CbGpPWpGaD
Acetylcysteine—Somnolence—Doxorubicin—bone cancer	0.000643	0.00352	CcSEcCtD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—MDM2—bone cancer	0.000639	0.000782	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Doxorubicin—bone cancer	0.000637	0.00349	CcSEcCtD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—JUN—bone cancer	0.000636	0.000778	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TP53—bone cancer	0.000635	0.000777	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000633	0.000775	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—JUN—bone cancer	0.000625	0.000765	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000625	0.00342	CcSEcCtD
Acetylcysteine—SLCO1B1—Metabolism—NT5C3A—bone cancer	0.000624	0.000763	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—MDM2—bone cancer	0.000623	0.000762	CbGpPWpGaD
Acetylcysteine—Urticaria—Epirubicin—bone cancer	0.000621	0.0034	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—bone cancer	0.000618	0.00338	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—bone cancer	0.000616	0.00337	CcSEcCtD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.00061	0.000747	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—MDM2—bone cancer	0.00061	0.000746	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—GSTP1—bone cancer	0.000604	0.000739	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TP53—bone cancer	0.000596	0.000729	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000596	0.000729	CbGpPWpGaD
Acetylcysteine—Pruritus—Methotrexate—bone cancer	0.000591	0.00324	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—CDK4—bone cancer	0.00059	0.000722	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MET—bone cancer	0.00059	0.000722	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	0.000585	0.000716	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—ATF1—bone cancer	0.000583	0.000714	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—KIT—bone cancer	0.000582	0.000712	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Epirubicin—bone cancer	0.000576	0.00315	CcSEcCtD
Acetylcysteine—GRIN2B—Developmental Biology—CDK4—bone cancer	0.000575	0.000704	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MET—bone cancer	0.000575	0.000704	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—JUN—bone cancer	0.000575	0.000703	CbGpPWpGaD
Acetylcysteine—Urticaria—Doxorubicin—bone cancer	0.000575	0.00315	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—bone cancer	0.000572	0.00313	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—MDM2—bone cancer	0.000565	0.000691	CbGpPWpGaD
Acetylcysteine—Pruritus—Epirubicin—bone cancer	0.000553	0.00303	CcSEcCtD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—JUN—bone cancer	0.000553	0.000676	CbGpPWpGaD
Acetylcysteine—Dizziness—Methotrexate—bone cancer	0.000553	0.00302	CcSEcCtD
Acetylcysteine—CHUK—Signaling by SCF-KIT—EGFR—bone cancer	0.000551	0.000675	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00055	0.000673	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—BRAF—bone cancer	0.000547	0.000669	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PTGS2—bone cancer	0.000545	0.000667	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Doxorubicin—bone cancer	0.000533	0.00292	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—bone cancer	0.000531	0.00291	CcSEcCtD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—JUN—bone cancer	0.00053	0.000649	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—ATF1—bone cancer	0.000529	0.000647	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—KIT—bone cancer	0.000528	0.000646	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—EGFR—bone cancer	0.000528	0.000646	CbGpPWpGaD
Acetylcysteine—Rash—Methotrexate—bone cancer	0.000527	0.00288	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—bone cancer	0.000526	0.00288	CcSEcCtD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000522	0.000639	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—EGFR—bone cancer	0.000519	0.000635	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MMP9—bone cancer	0.000519	0.000635	CbGpPWpGaD
Acetylcysteine—Dizziness—Epirubicin—bone cancer	0.000517	0.00283	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—bone cancer	0.000512	0.0028	CcSEcCtD
Acetylcysteine—GRIN2B—Axon guidance—MMP9—bone cancer	0.000506	0.000619	CbGpPWpGaD
Acetylcysteine—Vomiting—Epirubicin—bone cancer	0.000497	0.00272	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—bone cancer	0.000496	0.00272	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by NGF—BRAF—bone cancer	0.000496	0.000607	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—EGFR—bone cancer	0.000496	0.000607	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—EGFR—bone cancer	0.000493	0.000604	CbGpPWpGaD
Acetylcysteine—Rash—Epirubicin—bone cancer	0.000493	0.0027	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—bone cancer	0.000493	0.0027	CcSEcCtD
Acetylcysteine—GRIN1—Developmental Biology—MMP2—bone cancer	0.000492	0.000602	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—EGFR—bone cancer	0.000491	0.000601	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—EGFR—bone cancer	0.000489	0.000598	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.000482	0.000589	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP2—bone cancer	0.00048	0.000587	CbGpPWpGaD
Acetylcysteine—Dizziness—Doxorubicin—bone cancer	0.000478	0.00262	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—bone cancer	0.000465	0.00254	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—bone cancer	0.00046	0.00252	CcSEcCtD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.00046	0.000563	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—EGFR—bone cancer	0.00046	0.000563	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—EGFR—bone cancer	0.00046	0.000563	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—MDM2—bone cancer	0.000458	0.000561	CbGpPWpGaD
Acetylcysteine—Rash—Doxorubicin—bone cancer	0.000456	0.0025	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—bone cancer	0.000456	0.00249	CcSEcCtD
Acetylcysteine—CHUK—Signaling by EGFR—EGFR—bone cancer	0.000456	0.000558	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000452	0.000553	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—EGFR—bone cancer	0.00045	0.00055	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000438	0.000536	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—bone cancer	0.000437	0.000534	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—EGFR—bone cancer	0.000435	0.000532	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000433	0.000529	CbGpPWpGaD
Acetylcysteine—Nausea—Doxorubicin—bone cancer	0.00043	0.00235	CcSEcCtD
Acetylcysteine—CHUK—B Cell Activation—EGFR—bone cancer	0.000425	0.000521	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GRM4—bone cancer	0.000423	0.000517	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—RGS1—bone cancer	0.000423	0.000517	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—EGFR—bone cancer	0.000419	0.000513	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—bone cancer	0.000417	0.00051	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MDM2—bone cancer	0.000416	0.000508	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—EGFR—bone cancer	0.000409	0.0005	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000407	0.000498	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—ENO2—bone cancer	0.000389	0.000476	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—EGFR—bone cancer	0.000386	0.000472	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GRM4—bone cancer	0.000383	0.000469	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—RGS1—bone cancer	0.000383	0.000469	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MMP9—bone cancer	0.00037	0.000453	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GRM1—bone cancer	0.000367	0.000449	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—bone cancer	0.000365	0.000447	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000363	0.000444	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—DHFR—bone cancer	0.000361	0.000442	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MMP9—bone cancer	0.000361	0.000441	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—bone cancer	0.000357	0.000437	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ATF1—bone cancer	0.00034	0.000416	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GRM1—bone cancer	0.000332	0.000407	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KIT—bone cancer	0.000332	0.000406	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL3—bone cancer	0.000331	0.000405	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KIT—bone cancer	0.000319	0.00039	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—EGFR—bone cancer	0.000313	0.000383	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—bone cancer	0.000313	0.000383	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ATF1—bone cancer	0.000308	0.000377	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KIT—bone cancer	0.000301	0.000368	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL3—bone cancer	0.0003	0.000368	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EGFR—bone cancer	0.000299	0.000366	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—bone cancer	0.000292	0.000357	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KIT—bone cancer	0.000289	0.000354	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—bone cancer	0.000284	0.000347	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ENO2—bone cancer	0.000273	0.000334	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFBR2—bone cancer	0.000262	0.00032	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MDM2—bone cancer	0.000261	0.00032	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SMO—bone cancer	0.000258	0.000316	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—DHFR—bone cancer	0.000254	0.00031	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—MDM2—bone cancer	0.000251	0.000307	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MDM2—bone cancer	0.000237	0.00029	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GNA11—bone cancer	0.000237	0.00029	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GNA11—bone cancer	0.000236	0.000289	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SMO—bone cancer	0.000234	0.000287	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—MDM2—bone cancer	0.000228	0.000278	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—JUN—bone cancer	0.000227	0.000278	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ATF1—bone cancer	0.00022	0.000269	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP3A4—bone cancer	0.000215	0.000263	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GNA11—bone cancer	0.000214	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL3—bone cancer	0.000214	0.000262	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000214	0.000262	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—JUN—bone cancer	0.000206	0.000252	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ATF1—bone cancer	0.000199	0.000244	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL3—bone cancer	0.000194	0.000238	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KIT—bone cancer	0.000193	0.000237	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTP1—bone cancer	0.000184	0.000225	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFBR2—bone cancer	0.000183	0.000224	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—bone cancer	0.000179	0.000219	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KIT—bone cancer	0.000178	0.000218	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIT—bone cancer	0.000175	0.000214	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IGF1R—bone cancer	0.000172	0.000211	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—bone cancer	0.000172	0.00021	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—bone cancer	0.000168	0.000205	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFBR2—bone cancer	0.000166	0.000203	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—bone cancer	0.000162	0.000198	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IGF1R—bone cancer	0.000156	0.000191	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—bone cancer	0.000156	0.00019	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—bone cancer	0.000152	0.000186	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—bone cancer	0.000141	0.000172	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—bone cancer	0.000138	0.000169	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—bone cancer	0.000136	0.000166	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—bone cancer	0.000132	0.000162	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—bone cancer	0.000125	0.000153	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—bone cancer	0.00012	0.000147	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—bone cancer	0.000117	0.000144	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—bone cancer	0.000113	0.000139	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—bone cancer	0.000107	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—bone cancer	0.000104	0.000127	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—bone cancer	9.84e-05	0.00012	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—bone cancer	9.61e-05	0.000118	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—bone cancer	9.52e-05	0.000116	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—bone cancer	9.43e-05	0.000115	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—bone cancer	8.93e-05	0.000109	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—bone cancer	8.56e-05	0.000105	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP9—bone cancer	8.32e-05	0.000102	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—bone cancer	7.76e-05	9.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP9—bone cancer	7.55e-05	9.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—bone cancer	6.73e-05	8.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—bone cancer	6.1e-05	7.46e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—bone cancer	5.65e-05	6.91e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—bone cancer	5.12e-05	6.27e-05	CbGpPWpGaD
